Related Funds
Fund Name | Location |
ARCH Healthcare Fund | - |
Babilou | Courbevoie, France, Ile-de-France |
Caitong Asset | China, Shanghai |
Chasestone Capital | China, Shanghai |
Citizens Bank | Providence, Rhode Island, United States |
Cypress Point Partners | Houston, Texas, United States |
Elliott Management Corp. | New York, New York, United States |
International Real Returns | - |
Macro | California, Los Angeles, United States |
Ojai Goliad | Dallas, Texas, United States |
Print Marketing | - |
Rio Tinto | Australia, Melbourne, Victoria |
Shanghai SIIC Fund Management | China, Shanghai |
The Arena Capital | China, Shanghai |
Tugboat | - |
W. R. Berkley Innovation Labs | New York, New York, United States |
World Gold Council | England, London, United Kingdom |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Cancer Cell | $1M | 18 Jun 2024 | Suzhou, Jiangsu, China | ||
Douhe Technology | 24 Apr 2024 | Foshan, Guangdong, China | |||
Chengling Microelectronics | 08 Feb 2024 | Hefei, Anhui, China | |||
Qingtian Intelligent | 01 Jul 2023 | Hefei, Anhui, China | |||
INNOMED | 07 May 2022 | Gusu District, Jiangsu, China | |||
Suntech Pharmacy | 01 May 2022 | Guangdong, Tianjin, China | |||
Chengling Microelectronics | 27 Apr 2022 | Hefei, Anhui, China | |||
iSMARTWAYS | 27 Dec 2021 | Jiang'an District, Hubei, China | |||
Huibang Biological | 24 Dec 2021 | Shushan District, Anhui, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Cancer Cell | $1M | 18 Jun 2024 | Suzhou, Jiangsu, China | ||
Douhe Technology | 24 Apr 2024 | Foshan, Guangdong, China | |||
Chengling Microelectronics | 08 Feb 2024 | Hefei, Anhui, China | |||
Qingtian Intelligent | 01 Jul 2023 | Hefei, Anhui, China | |||
INNOMED | 07 May 2022 | Gusu District, Jiangsu, China | |||
Suntech Pharmacy | 01 May 2022 | Guangdong, Tianjin, China | |||
Chengling Microelectronics | 27 Apr 2022 | Hefei, Anhui, China | |||
iSMARTWAYS | 27 Dec 2021 | Jiang'an District, Hubei, China | |||
Huibang Biological | 24 Dec 2021 | Shushan District, Anhui, China |